Onvansertib is a third-generation, oral adenosine triphosphate which inhibits tumor growth in patients with acute myeloid leukemia (AML) who are resistant to venetoclax (Venclexta).Reference standards of Onvansertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Onvansertib-API [catalogue_number] => PA 15 0850000 [category_ids] => ,78,75,76,82, [chemical_name] => [weight] => 532.53 [form] => C24H27F3N8O3 [cas] => 1034616-18-6 [pslug] => 1034616-18-6-onvansertib-pa150850000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 15 0850000
CAS :
Molecular Formula : C24H27F3N8O3
Molecular Weight : 532.53
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....